TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
EDIT

Editas Medicine Inc

Healthcare · Biotechnology

2.80$ +4.8% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Editas Medicine Inc (EDIT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 237 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EDIT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
505 499 440 385 328 342 264 211 202 187 149 237
359 341 306 286 271 289 225 183 177 164 128 218
83 124 69 64 96 132 139 139 166 147 124 182
350 323 296 279 265 270 221 179 166 147 124 212
2.4 10 0.2 0.2 0.1 16 0.5 0.6 8.1 15 2.6 2.7
-9.0 0.0
43
144 150 146 153 152 207 201 191 188 159 145 132
59 63 66 74 72 77 73 66 62 46 40 68
9.7 24 12 18 16 15 13 6.1 6.1 11 14 6.5
10 8.3 8.0 14 12 5.5 5.5 6.7 3.2 2.6 4.3 4.7
360 349 294 232 176 134 62 19 13 27 4.4 105
-1,212 -1,231 -1,293 -1,361 -1,423 -1,468 -1,545 -1,598 -1,623 -1,629 -1,653 -1,672
82 82 82 82 82 83 83 84 90 89 98 119

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?